--2025/Q1-- / 22.233M--
--2024/Q4-- / 34.208M--
--2024/Q3388.000K / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q183.000K / 0.000--
MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
NVIDIA
NVDA
US Stock MarketDetailed Quotes
KROS Keros Therapeutics
- 16.100
- +0.180+1.13%
Close Jan 3 16:00 ET
- 16.100
- 0.0000.00%
Post 20:01 ET
652.17MMarket Cap-3.08P/E (TTM)
16.524High15.740Low752.55KVolume15.900Open15.920Pre Close12.10MTurnover2.13%Turnover RatioLossP/E (Static)40.51MShares73.00052wk High1.22P/B569.47MFloat Cap15.33052wk Low--Dividend TTM35.37MShs Float88.800Historical High--Div YieldTTM4.93%Amplitude15.330Historical Low16.076Avg Price1Lot Size
Keros Therapeutics Key Stats
Keros Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Keros Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data